Myelodysplastic syndrome
Big picture
Myelodysplastic syndrome (MDS) is a clonal stem-cell disorder of the bone marrow where the marrow is usually cellular, but blood production is ineffective and dysplastic. The result is the classic paradox:
hypercellular/dysplastic marrow → peripheral cytopenia.
For the exam, think of MDS in an older patient with unexplained macrocytic anemia, often with neutropenia and/or thrombocytopenia, a low reticulocyte count, and abnormal cells on smear. The major danger is progression to acute myeloid leukemia (AML).
The textbook emphasizes that MDS is a heterogeneous clonal hematopoietic stem-cell disorder with dysplasia in one or more cell lines
Public preview
Unlock this Internal Medicine topic
Choose monthly or annual access only when those offers are supplied by the catalog.
Log in to continueA recurring monthly subscription at $9.99/subject, renews until you cancel. By subscribing you agree to our Terms and Refund Policy, ask us to start access immediately, and accept that you lose your 14-day right of withdrawal once access begins.
Anki deck locked
Unlock the subject to access its study deck.
